CD63 and viral infectious disease: Cellular depletion of CD63 or treatment of cells with CD63 antibodies leads to decreased infectivity of HIV-1, HCV, LUJV, and oncogenic HPV types presenting CD63 as a more general mediator of virus infection (46, 55, 84, 88–90).